The stock of AngioDynamics Inc. (ANGO) has gone up by 4.48% for the week, with a -13.36% drop in the past month and a -33.15% drop in the past quarter. The volatility ratio for the week is 5.41%, and the volatility levels for the past 30 days are 5.05% for ANGO. . The simple moving average for the past 20 days is -3.99% for ANGO’s stock, with a -29.96% simple moving average for the past 200 days.
Is It Worth Investing in AngioDynamics Inc. (NASDAQ: ANGO) Right Now?
Additionally, the 36-month beta value for ANGO is 0.62. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The average price predicted by analysts for ANGO is $16.50, which is $9.04 above the current price. The public float for ANGO is 37.41M and currently, short sellers hold a 3.27% ratio of that float. The average trading volume of ANGO on September 20, 2023 was 617.82K shares.
ANGO) stock’s latest price update
AngioDynamics Inc. (NASDAQ: ANGO)’s stock price has soared by 4.48 in relation to previous closing price of 7.14. Nevertheless, the company has seen a gain of 4.48% in its stock price over the last five trading days. Seeking Alpha reported 2023-09-17 that AngioDynamics, Inc. posted mixed results in its FY’23 reports, with strong growth in its Med Tech division. The company’s focus going forward will be on its Med Tech segment, which has shown high growth and higher margins. It’s the economic performance that matters here, with investment and profitability trends drawn into question.
Analysts’ Opinion of ANGO
Many brokerage firms have already submitted their reports for ANGO stocks, with Raymond James repeating the rating for ANGO by listing it as a “Outperform.” The predicted price for ANGO in the upcoming period, according to Raymond James is $13 based on the research report published on April 17, 2023 of the current year 2023.
ANGO Trading at -11.24% from the 50-Day Moving Average
After a stumble in the market that brought ANGO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -65.90% of loss for the given period.
Volatility was left at 5.05%, however, over the last 30 days, the volatility rate increased by 5.41%, as shares sank -12.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.45% lower at present.
During the last 5 trading sessions, ANGO rose by +4.48%, which changed the moving average for the period of 200-days by -42.39% in comparison to the 20-day moving average, which settled at $7.72. In addition, AngioDynamics Inc. saw -45.82% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at ANGO starting from Helsel Dave, who sale 4,633 shares at the price of $12.95 back on Jan 31. After this action, Helsel Dave now owns 19,189 shares of AngioDynamics Inc., valued at $59,997 using the latest closing price.
Trowbridge Stephen A, the EVP and CFO of AngioDynamics Inc., purchase 1,083 shares at $13.82 during a trade that took place back on Oct 12, which means that Trowbridge Stephen A is holding 89,581 shares at $14,967 based on the most recent closing price.
Stock Fundamentals for ANGO
Current profitability levels for the company are sitting at:
- -5.51 for the present operating margin
- +45.89 for the gross margin
The net margin for AngioDynamics Inc. stands at -15.48. The total capital return value is set at -4.20, while invested capital returns managed to touch -11.89. Equity return is now at value -13.10, with -9.60 for asset returns.
Based on AngioDynamics Inc. (ANGO), the company’s capital structure generated 13.17 points at debt to equity in total, while total debt to capital is 11.64. Total debt to assets is 10.34, with long-term debt to equity ratio resting at 13.17. Finally, the long-term debt to capital ratio is 11.64.
When we switch over and look at the enterprise to sales, we see a ratio of 0.87, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 6.20 and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.95.
In conclusion, AngioDynamics Inc. (ANGO) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.